Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Worms on the brain: fatal meningoencephalitis from disseminated strongyloides infection.

Dokmeci O, Forshay B, Scholand SJ.

Conn Med. 2013 Jan;77(1):31-3.

PMID:
23427371
2.

Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.

Moura EB, Maia Mde O, Ghazi M, Amorim FF, Pinhati HM.

Braz J Infect Dis. 2012 Sep-Oct;16(5):479-81. doi: 10.1016/j.bjid.2012.08.008. Epub 2012 Sep 10.

3.

Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment.

Feely NM, Waghorn DJ, Dexter T, Gallen I, Chiodini P.

Anaesthesia. 2010 Mar;65(3):298-301. doi: 10.1111/j.1365-2044.2009.06196.x. Epub 2009 Dec 10.

4.

[Fulminant strongyloidiasis successfully treated by subcutaneous ivermectin: an autopsy case].

Takashima N, Yazawa S, Ishihara A, Sugimoto S, Shiomi K, Hiromatsu K, Nakazato M.

Rinsho Shinkeigaku. 2008 Jan;48(1):30-5. Japanese.

PMID:
18386629
5.

Late diagnosis of central nervous system involvement associated with lethal dissemination of Strongyloides stercoralis in an advanced HIV patient from Nigeria.

Ursini T, Polilli E, Fazii P, Ieraci A, Sindici G, Parruti G.

Int J Infect Dis. 2013 Apr;17(4):e280-2. doi: 10.1016/j.ijid.2012.11.031. Epub 2013 Feb 12.

6.

Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient.

Martin SJ, Cohen PR, MacFarlane DF, Grossman ME.

Skinmed. 2011 May-Jun;9(3):199-202.

PMID:
21675505
7.

Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.

Leung V, Al-Rawahi GN, Grant J, Fleckenstein L, Bowie W.

Am J Trop Med Hyg. 2008 Dec;79(6):853-5.

PMID:
19052292
8.

Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.

Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, Fleckenstein L, Baden LR.

Clin Infect Dis. 2005 Jul 1;41(1):e5-8. Epub 2005 May 11.

PMID:
15937753
9.

Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.

Turner SA, Maclean JD, Fleckenstein L, Greenaway C.

Am J Trop Med Hyg. 2005 Nov;73(5):911-4.

PMID:
16282302
10.

[Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].

Manrique-Rodríguez S, Martín-Rabadán P, Díaz-Cámara M, Fernández-Llamazares CM.

Med Clin (Barc). 2016 Apr 15;146(8):376-7. doi: 10.1016/j.medcli.2015.10.008. Epub 2015 Dec 2. Spanish. No abstract available.

PMID:
26654554
11.

Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.

Arch EL, Schaefer JT, Dahiya A.

Dermatol Online J. 2008 Dec 15;14(12):6.

12.

Strongyloides hyperinfection syndrome complications: a case report and review of the literature.

Najmuddin A, Hadique S, Parker J.

W V Med J. 2012 Jan-Feb;108(1):32-8. Review.

PMID:
25134190
13.

Minimal change nephrotic syndrome in a patient with strongyloidiasis.

Miyazaki M, Tamura M, Kabashima N, Serino R, Shibata T, Miyamoto T, Furuno Y, Nishio T, Ohara J, Sakurai T, Otsuji Y.

Clin Exp Nephrol. 2010 Aug;14(4):367-71. doi: 10.1007/s10157-010-0273-4. Epub 2010 Mar 12.

PMID:
20224878
14.

Alicata disease: neuroinfestation by Angiostrongylus cantonensis in Recife, Pernambuco, Brazil.

Lima AR, Mesquita SD, Santos SS, Aquino ER, Rosa Lda R, Duarte FS, Teixeira AO, Costa ZR, Ferreira ML.

Arq Neuropsiquiatr. 2009 Dec;67(4):1093-6. No abstract available.

15.

Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature.

Donadello K, Cristallini S, Taccone FS, Lorent S, Vincent JL, de Backer D, Jacobs F.

Int J Antimicrob Agents. 2013 Dec;42(6):580-3. doi: 10.1016/j.ijantimicag.2013.07.015. Epub 2013 Sep 7.

PMID:
24269075
16.

Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient.

Briasoulis A, Psevdos G.

South Med J. 2011 Jan;104(1):72-3. doi: 10.1097/SMJ.0b013e3181f61647. No abstract available.

PMID:
21119560
17.

Pulmonary strongyloidiasis.

Jayaprakash B, Sandhya S, Anithakumari K.

J Assoc Physicians India. 2009 Jul;57:535-6.

PMID:
20329418
18.

Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.

Benvenuti F, Carrascosa JM, Boada A, Ferrandiz C.

Eur J Dermatol. 2009 Jul-Aug;19(4):404-5. doi: 10.1684/ejd.2009.0701. Epub 2009 May 25. No abstract available.

PMID:
19467975
19.

Dissemination: the fatal risk for a missed diagnosis of Strongyloides stercoralis infection.

Boscolo M, Bisoffi Z.

J Infect. 2007 Sep;55(3):284-5. Epub 2007 Mar 26. No abstract available.

PMID:
17368549
20.

Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.

Hauber HP, Galle J, Chiodini PL, Rupp J, Birke R, Vollmer E, Zabel P, Lange C.

Infection. 2005 Oct;33(5-6):383-6.

PMID:
16258873

Supplemental Content

Support Center